Cerner Corporation (CERN)

CERN (NASDAQ:Computer Software & Services)
$97.12
neg -1.89
-1.91%
Today's Range: 96.87 - 99.21 | CERN Avg Daily Volume: 764,200
Last Update: 06/19/13 - 4:00 PM EDT
Volume: 459,342
YTD Performance: 27.74%
Open: $99.08
Previous Close: $99.01
52 Week Range: $67.64 - $100.00
Oustanding Shares: 171,879,430
Market Cap: 17,017,782,364
6-Month Chart
TheStreet Ratings Grade for CERN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 9 9 10
Moderate Buy 0 0 1 1
Hold 9 7 6 6
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.22 2.06 2.00 1.94
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 01/10/06
Price Earnings Ratio: 41.78
Price Earnings Comparisons:
CERN Sector Avg. S&P 500
41.78 41.80 17.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
8.66% 12.98% 145.62%
GROWTH 12 Mo 3 Yr CAGR
Revenue 21.00 0.59 0.17
Net Income 29.50 1.05 0.27
EPS 28.40 0.93 0.24
Earnings for CERN:
EBITDA 0.79B
Revenue 2.67B
Average Earnings Estimates
Qtr (06/13) Qtr (09/13) FY (12/13) FY (12/14)
Average Estimate $0.63 $0.67 $2.64 $3.09
Number of Analysts 9 9 9 9
High Estimate $0.66 $0.68 $2.70 $3.25
Low Estimate $0.60 $0.62 $2.52 $2.81
Prior Year $0.56 $0.56 $2.26 $2.64
Growth Rate (Year over Year) 12.90% 19.05% 16.72% 17.23%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Bearish
Aug 02, 2012 | 7:58 AM EDT
CERN was downgraded to Market Perform, Leerink Swann said. Bookings growth is starting to decelerate. 
But the viability of the rally has been called into question.

An E-Health Play Real Money Pro($)

Wouldn't it be great if a company could do for medical records what others are doing for smart wallets?

Identifying the Outperformers Real Money Pro($)

My focus is on stocks with strong fundamentals showing relative price strength that are under accumulation.
The early dip gets bought, and program trading kicks in.
If this market breaks out, these names -- not the old guard -- will lead the market higher.

Don't Chase Growth Real Money Pro($)

Buying a growth stock when it’s overextended can result in unnecessary losses.
Even if Cerner is up sharply at the open, it's still a buy.
With hundreds of competing systems tracking medical records, this name is a top pick to grab more market share.
As the market eases off its correction, I’m dipping in with a couple of plays in healthcare and tech.

Columnist Conversation / Market Updates

| Jun 20, 2013
| 1:22 AM EDT
Has the TLT finally found support? More importantly, can it hold it? I think there is a case to be made for it... Here i...
| Jun 19, 2013
| 8:36 PM EDT
Faced with a capacity shortfall and possible energy shortages, Texas power producers dusted off some old plants and put ...

Our Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.